![H. Hogan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
H. Hogan
Direktör/Styrelseledamot på
METACRINE, INC.
Profil
H.
Michael Hogan currently works at Otonomy, Inc., as Director from 2023 and Metacrine, Inc., as Director from 2023.
Mr. Hogan also formerly worked at Nabriva Therapeutics Plc, as Chief Executive Officer and Armanino LLP (United States), as Partner.
Mr. Hogan received his undergraduate degree from Colgate University.
Aktiva positioner av H. Hogan
| Företag | Position | Start |
|---|---|---|
| METACRINE, INC. | Direktör/Styrelseledamot | 2023-03-23 |
| OTONOMY | Direktör/Styrelseledamot | 2023-02-15 |
Tidigare kända positioner av H. Hogan
| Företag | Position | Slut |
|---|---|---|
Armanino LLP (United States)
 Armanino LLP (United States) Miscellaneous Commercial ServicesCommercial Services Operates as an accounting and consulting firm | Företagsledare/Principal | - |
| NABRIVA THERAPEUTICS PLC | Verkställande Direktör | - |
H. Hogans utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
20
Första gradens relationer
5
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Colgate University
 Colgate University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Armanino LLP (United States)
Armanino LLP (United States) Miscellaneous Commercial ServicesCommercial Services Operates as an accounting and consulting firm | Commercial Services |
Otonomy, Inc.
 Otonomy, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for neurology diseases | Health Technology |
Metacrine, Inc.
 Metacrine, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in discovery and development of therapies for patients with liver and gastrointestinal diseases | Health Technology |
Nabriva Therapeutics Plc
 Nabriva Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the research, development, and commercialization of novel anti-infective agents | Health Technology |
